Pfizer-backed UK biotech raises £25M to advance mitophagy pipeline
Mission Therapeutics has secured £25.2 million ($32.2 million) in a Series D raise to extend its runway through 2026 and support the development of its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
